Clinical value of circulating endothelial cell detection in oncology

Drug Discovery Today

Volumn 17, Issue 13-14, 2012, Pages 710-717

  Kraan, Jaco ^a   Sleijfer, Stefan ^a   Foekens, John A ^a   Gratama, Jan W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN RECEPTOR LIKE KINASE 1; ANGIOGENESIS INHIBITOR; BEVACIZUMAB; BIOLOGICAL MARKER; CARBOPLATIN; CEDIRANIB; CYCLOPHOSPHAMIDE; DOCETAXEL; ENDOSTATIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ERLOTINIB; METHOTREXATE; PACLITAXEL; PLACENTAL GROWTH FACTOR; SORAFENIB; SUNITINIB; THALIDOMIDE; THROMBOMODULIN; VASCULAR TARGETING AGENT; VASCULOTROPIN;

ANGIOGENESIS; BREAST TUMOR; CANCER PROGNOSIS; CANCER SURVIVAL; CASTRATION RESISTANT PROSTATE CANCER; CELL DIFFERENTIATION; CELL ISOLATION; CELL LOSS; CIRCULATING ENDOTHELIAL CELL; CLINICAL TRIAL (TOPIC); COLORECTAL TUMOR; DISEASE ACTIVITY; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; FLOW CYTOMETRY; GASTROINTESTINAL STROMAL TUMOR; GLIOBLASTOMA; HUMAN; KIDNEY TUMOR; LUNG NON SMALL CELL CANCER; MICROSCOPY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PANCREAS TUMOR; POSITRON EMISSION TOMOGRAPHY; PROGRESSION FREE SURVIVAL; REVIEW; TUMOR VASCULARIZATION;

ANIMALS; ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS; CLINICAL TRIALS AS TOPIC; ENDOTHELIAL CELLS; FLOW CYTOMETRY; HUMANS; IMMUNOMAGNETIC SEPARATION; MEDICAL ONCOLOGY; NEOPLASMS; NEOPLASTIC CELLS, CIRCULATING; NEOVASCULARIZATION, PATHOLOGIC; PREDICTIVE VALUE OF TESTS; TUMOR MARKERS, BIOLOGICAL;

EID: 84863505254     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2012.01.011     Document Type: Review

References (86)

1. G.N. Naumov A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype J. Natl. Cancer Inst. 98 2006 316 325 (Pubitemid 43338211)
2. M.H. Strijbos Circulating endothelial cells in oncology: pitfalls and promises Br. J. Cancer 98 2008 1731 1735 (Pubitemid 351748848)
3. P. Carmeliet, and R.K. Jain Molecular mechanisms and clinical applications of angiogenesis Nature 473 2011 298 307
4. J.A. Nagy Heterogeneity of the tumor vasculature Semin. Thromb. Hemost. 36 2010 321 331
5. D.D. Hu-Lowe Targeting activin receptor-like kinase 1 inhibits angiogenesis and tumorigenesis through a mechanism of action complementary to anti-VEGF therapies Cancer Res. 71 2011 1362 1373
6. D.W. Siemann Differentiation and definition of vascular-targeted therapies Clin. Cancer Res. 11 2005 416 420 (Pubitemid 40116863)
7. F. Bertolini Molecular and cellular biomarkers for angiogenesis in clinical oncology Drug Discov. Today 12 2007 806 812 (Pubitemid 47539970)
8. R.K. Jain Biomarkers of response and resistance to antiangiogenic therapy Nat. Rev. Clin. Oncol. 6 2009 327 338
9. R. Longo, and G. Gasparini Anti-VEGF therapy: the search for clinical biomarkers Expert Rev. Mol. Diagn. 8 2008 301 314 (Pubitemid 351724709)
10. L. Bonello Endothelial injury induced by coronary angioplasty triggers mobilization of endothelial progenitor cells in patients with stable coronary artery disease J. Thromb. Haemost. 4 2006 979 981
11. M. Mutin Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating endothelial cells Blood 93 1999 2951 2958 (Pubitemid 29200786)
12. F. George Demonstration of Rickettsia conorii-induced endothelial injury in vivo by measuring circulating endothelial cells, thrombomodulin, and von Willebrand factor in patients with Mediterranean spotted fever Blood 82 1993 2109 2116 (Pubitemid 23293994)
13. M. Mutunga Circulating endothelial cells in patients with septic shock Am. J. Respir. Crit. Care Med. 163 2001 195 200 (Pubitemid 32095270)
14. E. Percivalle Circulating endothelial giant cells permissive for human cytomegalovirus (HCMV) are detected in disseminated HCMV infections with organ involvement J. Clin. Invest. 92 1993 663 670 (Pubitemid 23262383)
15. L. Camoin-Jau Circulating endothelial cells in Behcet's disease with cerebral thrombophlebitis Thromb. Haemost. 83 2000 631 632 (Pubitemid 30201145)
16. R. Clancy Circulating activated endothelial cells in systemic lupus erythematosus: further evidence for diffuse vasculopathy Arthritis Rheum. 44 2001 1203 1208 (Pubitemid 32433629)
17. T.M. Bull Circulating endothelial cells in pulmonary hypertension Thromb. Haemost. 90 2003 698 703 (Pubitemid 37287638)
18. A. Solovey Circulating activated endothelial cells in sickle cell anemia N. Engl. J. Med. 337 1997 1584 1590 (Pubitemid 27509761)
19. M.H. Strijbos Circulating endothelial cells: a potential parameter of organ damage in sickle cell anemia? Blood Cells Mol. Dis. 43 2009 63 67
20. A. Woywodt Circulating endothelial cells as a marker of endothelial damage in allogeneic hematopoietic stem cell transplantation Blood 103 2004 3603 3605 (Pubitemid 38525700)
21. A. Woywodt Elevated numbers of circulating endothelial cells in renal transplant recipients Transplantation 76 2003 1 4 (Pubitemid 36877106)
22. F. Bertolini The multifaceted circulating endothelial cell in cancer: towards marker and target identification Nat. Rev. Cancer 6 2006 835 845 (Pubitemid 44629895)
23. G. Furstenberger Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer Br. J. Cancer 94 2006 524 531 (Pubitemid 43289756)
24. P.K. Goon Circulating endothelial cells: markers of vascular dysfunction Clin. Lab. 51 2005 531 538 (Pubitemid 41644193)
25. P.K. Goon Detection and quantification of mature circulating endothelial cells using flow cytometry and immunomagnetic beads: a methodological comparison Thromb. Haemost. 96 2006 45 52 (Pubitemid 44160870)
26. J.L. Rowand Endothelial cells in peripheral blood of healthy subjects and patients with metastatic carcinomas Cytometry A 71 2007 105 113 (Pubitemid 46238939)
27. M.H. Strijbos Circulating endothelial cells, circulating tumour cells, tissue factor, endothelin-1 and overall survival in prostate cancer patients treated with docetaxel Eur. J. Cancer 46 2010 2027 2035
28. M.H. Strijbos Cells meeting our immunophenotypic criteria of endothelial cells are large platelets Cytometry B Clin. Cytom. 72 2007 86 93 (Pubitemid 46365536)
29. P. Mancuso Validation of a standardized method for enumerating circulating endothelial cells and progenitors: flow cytometry and molecular and ultrastructural analyses Clin. Cancer Res. 15 2009 267 273
30. A. Widemann CD146-based immunomagnetic enrichment followed by multiparameter flow cytometry: a new approach to counting circulating endothelial cells J. Thromb. Haemost. 6 2008 869 876 (Pubitemid 351524550)
31. P. Mancuso Resting and activated endothelial cells are increased in the peripheral blood of cancer patients Blood 97 2001 3658 3661
32. D.A. Smirnov Global gene expression profiling of circulating endothelial cells in patients with metastatic carcinomas Cancer Res. 66 2006 2918 2922
33. F. Dignat-George Detection of circulating endothelial cells: CD146-based magnetic separation enrichment or flow cytometric assay? J. Clin. Oncol. 25 2007 1 2 (author reply 3-5)
34. A. Woywodt Isolation and enumeration of circulating endothelial cells by immunomagnetic isolation: proposal of a definition and a consensus protocol J. Thromb. Haemost. 4 2006 671 677
35. P.K. Goon Circulating endothelial cells in malignant disease Future Oncol. 1 2005 813 820
36. C.G. Willett Efficacy, safety, and biomarkers of neoadjuvant bevacizumab, radiation therapy, and fluorouracil in rectal cancer: a multidisciplinary phase II study J. Clin. Oncol. 27 2009 3020 3026
37. R. Torrisi Preoperative bevacizumab combined with letrozole and chemotherapy in locally advanced ER- and/or PgR-positive breast cancer: clinical and biological activity Br. J. Cancer 99 2008 1564 1571
38. A.H. Ko A phase II study of bevacizumab plus erlotinib for gemcitabine-refractory metastatic pancreatic cancer Cancer Chemother. Pharmacol. 66 2010 1051 1057
39. M. Ronzoni Circulating endothelial cells and endothelial progenitors as predictive markers of clinical response to bevacizumab-based first-line treatment in advanced colorectal cancer patients Ann. Oncol. 21 2010 2382 2389
40. A. Calleri Predictive potential of angiogenic growth factors and circulating endothelial cells in breast cancer patients receiving metronomic chemotherapy plus bevacizumab Clin. Cancer Res. 15 2009 7652 7657
41. S. Dellapasqua Metronomic cyclophosphamide and capecitabine combined with bevacizumab in advanced breast cancer J. Clin. Oncol. 26 2008 4899 4905
42. L. Vroling VEGFR2 expressing circulating (progenitor) cell populations in volunteers and cancer patients Thromb. Haemost. 98 2007 440 450 (Pubitemid 47250249)
43. N. Jacques Quantification of circulating mature endothelial cells using a whole blood four-color flow cytometric assay J. Immunol. Methods 337 2008 132 143
44. F. Farace Levels of circulating CD45(dim)CD34(+)VEGFR2(+) progenitor cells correlate with outcome in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors Br. J. Cancer 104 2011 1144 1150
45. C. Rabascio Assessing tumor angiogenesis: increased circulating VE-cadherin RNA in patients with cancer indicates viability of circulating endothelial cells Cancer Res. 64 2004 4373 4377 (Pubitemid 38802446)
46. P. Mancuso Circulating endothelial-cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapy Blood 108 2006 452 459 (Pubitemid 44061341)
47. Y. Lin Origins of circulating endothelial cells and endothelial outgrowth from blood J. Clin. Invest. 105 2000 71 77 (Pubitemid 30036389)
48. B.A. Peters Contribution of bone marrow-derived endothelial cells to human tumor vasculature Nat. Med. 11 2005 261 262 (Pubitemid 40460552)
49. F. Timmermans Endothelial progenitor cells: identity defined? J. Cell. Mol. Med. 13 2009 87 102
50. B. Dome Circulating endothelial cells, bone marrow-derived endothelial progenitor cells and proangiogenic hematopoietic cells in cancer: from biology to therapy Crit. Rev. Oncol. Hematol. 69 2009 108 124
51. D.A. Ingram Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood Blood 104 2004 2752 2760 (Pubitemid 39434958)
52. J. Case Human CD34+ AC133+ VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors Exp. Hematol. 35 2007 1109 1118 (Pubitemid 46921310)
53. J.M. Roodhart Late release of circulating endothelial cells and endothelial progenitor cells after chemotherapy predicts response and survival in cancer patients Neoplasia 12 2010 87 94
54. R.S. Bhatt Increased mobilisation of circulating endothelial progenitors in von Hippel-Lindau disease and renal cell carcinoma Br. J. Cancer 105 2011 112 117
55. P. Beaudry Differential effects of vascular endothelial growth factor receptor-2 inhibitor ZD6474 on circulating endothelial progenitors and mature circulating endothelial cells: implications for use as a surrogate marker of antiangiogenic activity Clin. Cancer Res. 11 2005 3514 3522 (Pubitemid 40627906)
56. D. Malka Clinical value of circulating endothelial cell levels in metastatic colorectal cancer patients treated with first-line chemotherapy and bevacizumab Ann. Oncol. 2011 (Epub ahead of print)
57. S. Matsusaka Circulating endothelial cells predict for response to bevacizumab-based chemotherapy in metastatic colorectal cancer Cancer Chemother. Pharmacol. 68 2010 763 768
58. L.H. Simkens The predictive and prognostic value of circulating endothelial cells in advanced colorectal cancer patients receiving first-line chemotherapy and bevacizumab Ann. Oncol. 21 2010 2447 2448
59. F.C. Bidard Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy Ann. Oncol. 21 2010 1765 1771
60. V. Gruenwald Circulating endothelial cells are an early predictor in renal cell carcinoma for tumor response to sunitinib BMC Cancer 10 2010 695
61. A. Norden-Zfoni Blood-based biomarkers of SU11248 activity and clinical outcome in patients with metastatic imatinib-resistant gastrointestinal stromal tumor Clin. Cancer Res. 13 2007 2643 2650 (Pubitemid 46788031)
62. T.T. Batchelor AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients Cancer Cell 11 2007 83 95 (Pubitemid 46075199)
63. M. Kawaishi Circulating endothelial cells in non-small cell lung cancer patients treated with carboplatin and paclitaxel J. Thorac. Oncol. 4 2009 208 213
64. Y.M. Ning Phase II trial of bevacizumab, thalidomide, docetaxel, and prednisone in patients with metastatic castration-resistant prostate cancer J. Clin. Oncol. 28 2010 2070 2076
65. L. Vroling Increased numbers of small circulating endothelial cells in renal cell cancer patients treated with sunitinib Angiogenesis 12 2009 69 79
66. I. Celik Therapeutic efficacy of endostatin exhibits a biphasic dose-response curve Cancer Res. 65 23 2005 11044 11050 (Pubitemid 41713375)
67. K. Yamada Phase I dose-escalation study and biomarker analysis of E7080 in patients with advanced solid tumors Clin. Cancer Res. 17 2011 2528 2537
68. L.V. Beerepoot Phase I clinical evaluation of weekly administration of the novel vascular-targeting agent, ZD6126, in patients with solid tumors J. Clin. Oncol. 24 2006 1491 1498 (Pubitemid 46638769)
69. S. Seaman Genes that distinguish physiological and pathological angiogenesis Cancer Cell 11 2007 539 554 (Pubitemid 46856908)
70. B. St Croix Genes expressed in human tumor endothelium Science 289 2000 1197 1202 (Pubitemid 30650733)
71. A. Nanda TEM8 interacts with the cleaved C5 domain of collagen alpha 3(VI) Cancer Res. 64 2004 817 820 (Pubitemid 38176877)
72. R. Mutuberria Isolation of human antibodies to tumor-associated endothelial cell markers by in vitro human endothelial cell selection with phage display libraries J. Immunol. Methods 287 2004 31 47 (Pubitemid 38510207)
73. K. Hida Tumor-associated endothelial cells with cytogenetic abnormalities Cancer Res. 64 2004 8249 8255 (Pubitemid 39491762)
74. M. Mura Identification and angiogenic role of the novel tumor endothelial marker CLEC14A Oncogene 2011 (Epub ahead of print)
75. X. Zang Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas Mod. Pathol. 23 2010 1104 1112
76. J.L. Li, and A.L. Harris The potential of new tumor endothelium-specific markers for the development of antivascular therapy Cancer Cell 11 2007 478 481 (Pubitemid 46856912)
77. S. Matsusaka Circulating endothelial progenitors and CXCR4-positive circulating endothelial cells are predictive markers for bevacizumab Cancer 117 2011 4026 4032
78. L.V. Beerepoot Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients Ann. Oncol. 15 2004 139 145 (Pubitemid 38139616)
79. F. Sabatier Circulating endothelial cells, microparticles and progenitors: key players towards the definition of vascular competence J. Cell. Mol. Med. 13 2009 454 471
80. P.K. Goon Circulating endothelial cells and circulating progenitor cells in breast cancer: relationship to endothelial damage/dysfunction/apoptosis, clinicopathologic factors, and the Nottingham Prognostic Index Neoplasia 11 2009 771 779
81. G. Moroni Increased levels of circulating endothelial cells in chronic periaortitis as a marker of active disease Kidney Int. 68 2005 562 568 (Pubitemid 43323111)
82. G.L. Dixon High-level endothelial E-selectin (CD62E) cell adhesion molecule expression by a lipopolysaccharide-deficient strain of Neisseria meningitidis despite poor activation of NF-kappaB transcription factor Clin. Exp. Immunol. 135 2004 85 93 (Pubitemid 38067931)
83. T.B. Corcoran The influence of propofol on P-selectin expression and nitric oxide production in re-oxygenated human umbilical vein endothelial cells Acta Anaesthesiol. Scand. 50 2006 348 354
84. T. Scholzen, and J. Gerdes The Ki-67 protein: from the known and the unknown J. Cell. Physiol. 182 2000 311 322 (Pubitemid 30054364)
85. D.W. Miller Elevated expression of endoglin, a component of the TGF-beta-receptor complex, correlates with proliferation of tumor endothelial cells Int. J. Cancer 81 1999 568 572 (Pubitemid 29203054)
86. A.M. Ali Determining circulating endothelial cells using CellSearch system during preoperative systemic chemotherapy in breast cancer patients Eur. J. Cancer 47 2011 2265 2272